Chapter 299 The skyrocketing growth brought about by new themes and new business formats

December 19, 2023 is Sunday 2...................................... ................................................................. ................................................................. ................................................................. ............................

Through review, Yuansheng discovered a stock with a unique theme and relatively new industry. Its stock price has been fluctuating continuously in recent weeks. Yesterday, it rose by 13.80% and closed at 5.74%. It has a clear upper shadow line and is a typical immortal. Guiding the way (such a K-line is easy to rise)........................................ ................................................................. ....................................

Let’s take a look at its subject matter------------------------------------------------- -----------------------

Investor: Hello, general manager, what are the characteristics of each of the subsidiaries "Hainan Tomorrow Vision" and "Guangzhou Bayes"? Thanks .

Company reply: Dear investors, hello! Guangzhou Bayes is a wholly-owned company of the company and a high-tech enterprise focused on exploring the application of innovative technology in the marketing industry. Hainan Tomorrow Vision focuses on providing innovative marketing solutions for brands. It is in the early stages of business exploration, the business volume is relatively small, and there is great uncertainty in future development. Investors are advised to make careful decisions and pay attention to investment risks. Thanks!

Investor: Hello, Secretary to the Board, the company has opened an account to innovate and explore the service model of the pharmaceutical industry. With the aging population accelerating, what are the company’s strengths in chronic disease drug marketing services? Thanks.

Company reply: Dear investors, hello! Thank you for your interest in the company. In the first half of 2023, the company will innovate and explore the service model in the pharmaceutical industry, help brand pharmaceutical companies carry out marketing services related to chronic disease tracking and management, and provide patients with long-term marketing services such as tracking and archiving, follow-up monitoring and so on. Relevant businesses are still in the early stages of exploration, and there is great uncertainty in future development. Investors are advised to make careful decisions and pay attention to investment risks. Thanks!

Zhang Sheng: "The company's reply to the questions of these two investors shows that the company is engaged in a relatively new industry. Combined with its recent K-line, does it indicate that it has greater opportunities in the near future?"

Yuan Sheng: "Theoretically, it's like this...................... .............So, I will buy it today.”

It is a music stock.

In the morning, stocks opened lower by 2.29%, Yuansheng is waiting............................. ................................................................. .............

At 9:30, after the stock price fluctuated, in less than a minute, when the stock price fell to the auspicious number of 10.18 yuan, Yuansheng decisively bought... ............................Finally, the cost was controlled at 10.28 yuan and the project ended. The battle on the first battlefield that opens up territory.

Write at night

................................................................. ................................................................. ................................................................. ................................................................. ................................................................. .....................

................................................................. ................................................................. ................................................................. ................................................................. ................................................................. .....................

................................................................. ................................................................. ................................................................. ................................................................. ................................................................. .....................